ARCHIVES

FDA Approves Folotyn For Peripheral T-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 32 No. 9 | September 25, 2009

Download PDF Visit The Full Archive

Related Articles

Improved Therapies For Cervical Cancer Said To Show Promise In Clinical Trials

March 26, 2004

Clinical Trials Approved by NCI CTEP Last Month

August 26, 2011

Starr Foundation Gives $100 Million To Form Cancer Consortium.

September 29, 2006

Insulin For Diabetes Increases Risk Of Colorectal Cancer

December 31, 2004

King Named Lombardi Center Deputy Director; SWOG Needs New Exec; Murphy Leaves St. Jude

July 22, 1988

In Congress: Mack Urges Stevens To Add $2 Billion To NIH Appropriations

June 13, 1997